-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 19, the NMPA official website released the latest drug approval information.
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical's 4 types of generic sildenafil citrate tablets were approved for listing and reviewed.
Sildenafil citrate tablets exceeded 2 billion yuan in 2017 and is expected to reach 2.
9 billion yuan in 2021
.
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical's 4 types of generic sildenafil citrate tablets were approved for listing and reviewed.
Sildenafil citrate tablets exceeded 2 billion yuan in 2017 and is expected to reach 2.
9 billion yuan in 2021
.
Figure 1: Yangtze River's latest approved product information
Source: NMPA official website
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co.
, Ltd.
submitted a generic listing application for sildenafil citrate tablets in June 2020, and was approved in November this year.
New products in the field of urinary system drugs after amine tablets and trospium chloride tablets
.
, Ltd.
submitted a generic listing application for sildenafil citrate tablets in June 2020, and was approved in November this year.
New products in the field of urinary system drugs after amine tablets and trospium chloride tablets
.
Figure 2: 2021E China city entity pharmacy terminal urinary system drug products TOP5 pattern
Source: China City Entity Pharmacy Terminal of Meinenet
Sildenafil citrate tablets are a major product among ED drugs.
According to data from Meinenet, since 2016, sildenafil citrate tablets have occupied half of the retail urinary system drug market, and are gradually increasing.
Expanding the leading advantage, the market share is expected to reach a new high in 2021, reaching 58.
81%
.
From a brand perspective, under the siege of domestic generic drugs, the market share of the original research drug company Pfizer is expected to drop to 43.
71% in 2021
.
According to data from Meinenet, since 2016, sildenafil citrate tablets have occupied half of the retail urinary system drug market, and are gradually increasing.
Expanding the leading advantage, the market share is expected to reach a new high in 2021, reaching 58.
81%
.
From a brand perspective, under the siege of domestic generic drugs, the market share of the original research drug company Pfizer is expected to drop to 43.
71% in 2021
.
Another ED best-selling product, tadalafil tablets, is expected to decline slightly in physical pharmacies in Chinese cities in 2021, but sales remain above 700 million yuan, which is still difficult to directly compete with sildenafil citrate tablets.
, And Eli Lilly still occupies more than 80% of the market share, and it is difficult for domestic brands to make efforts
.
, And Eli Lilly still occupies more than 80% of the market share, and it is difficult for domestic brands to make efforts
.
Source: Company announcement, NMPA official website, Minet database
Note: Meinenet China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.
.
The above sales are calculated based on the average retail price of the product at the terminal
.
On November 19, the NMPA official website released the latest drug approval information.
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical's 4 types of generic sildenafil citrate tablets were approved for listing and reviewed.
Sildenafil citrate tablets exceeded 2 billion yuan in 2017 and is expected to reach 2.
9 billion yuan in 2021
.
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical's 4 types of generic sildenafil citrate tablets were approved for listing and reviewed.
Sildenafil citrate tablets exceeded 2 billion yuan in 2017 and is expected to reach 2.
9 billion yuan in 2021
.
Figure 1: Yangtze River's latest approved product information
Source: NMPA official website
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co.
, Ltd.
submitted a generic listing application for sildenafil citrate tablets in June 2020, and was approved in November this year.
New products in the field of urinary system drugs after amine tablets and trospium chloride tablets
.
, Ltd.
submitted a generic listing application for sildenafil citrate tablets in June 2020, and was approved in November this year.
New products in the field of urinary system drugs after amine tablets and trospium chloride tablets
.
Figure 2: 2021E China city entity pharmacy terminal urinary system drug products TOP5 pattern
Source: China City Entity Pharmacy Terminal of Meinenet
Sildenafil citrate tablets are a major product among ED drugs.
According to data from Meinenet, since 2016, sildenafil citrate tablets have occupied half of the retail urinary system drug market, and are gradually increasing.
Expanding the leading advantage, the market share is expected to reach a new high in 2021, reaching 58.
81%
.
From a brand perspective, under the siege of domestic generic drugs, the market share of the original research drug company Pfizer is expected to drop to 43.
71% in 2021
.
According to data from Meinenet, since 2016, sildenafil citrate tablets have occupied half of the retail urinary system drug market, and are gradually increasing.
Expanding the leading advantage, the market share is expected to reach a new high in 2021, reaching 58.
81%
.
From a brand perspective, under the siege of domestic generic drugs, the market share of the original research drug company Pfizer is expected to drop to 43.
71% in 2021
.
Another ED best-selling product, tadalafil tablets, is expected to decline slightly in physical pharmacies in Chinese cities in 2021, but sales remain above 700 million yuan, which is still difficult to directly compete with sildenafil citrate tablets.
, And Eli Lilly still occupies more than 80% of the market share, and it is difficult for domestic brands to make efforts
.
, And Eli Lilly still occupies more than 80% of the market share, and it is difficult for domestic brands to make efforts
.
Source: Company announcement, NMPA official website, Minet database
Note: Meinenet China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.
.
The above sales are calculated based on the average retail price of the product at the terminal
.
On November 19, the NMPA official website released the latest drug approval information.
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical's 4 types of generic sildenafil citrate tablets were approved for listing and reviewed.
Sildenafil citrate tablets exceeded 2 billion yuan in 2017 and is expected to reach 2.
9 billion yuan in 2021
.
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical's 4 types of generic sildenafil citrate tablets were approved for listing and reviewed.
Sildenafil citrate tablets exceeded 2 billion yuan in 2017 and is expected to reach 2.
9 billion yuan in 2021
.
Figure 1: Yangtze River's latest approved product information
Source: NMPA official website
Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co.
, Ltd.
submitted a generic listing application for sildenafil citrate tablets in June 2020, and was approved in November this year.
New products in the field of urinary system drugs after amine tablets and trospium chloride tablets
.
, Ltd.
submitted a generic listing application for sildenafil citrate tablets in June 2020, and was approved in November this year.
New products in the field of urinary system drugs after amine tablets and trospium chloride tablets
.
Figure 2: 2021E China city entity pharmacy terminal urinary system drug products TOP5 pattern
Pharmacy drugstore Source: China City Entity Pharmacy Terminal of Meinenet
Sildenafil citrate tablets are a major product among ED drugs.
According to data from Meinenet, since 2016, sildenafil citrate tablets have occupied half of the retail urinary system drug market, and are gradually increasing.
Expanding the leading advantage, the market share is expected to reach a new high in 2021, reaching 58.
81%
.
From a brand perspective, under the siege of domestic generic drugs, the market share of the original research drug company Pfizer is expected to drop to 43.
71% in 2021
.
According to data from Meinenet, since 2016, sildenafil citrate tablets have occupied half of the retail urinary system drug market, and are gradually increasing.
Expanding the leading advantage, the market share is expected to reach a new high in 2021, reaching 58.
81%
.
From a brand perspective, under the siege of domestic generic drugs, the market share of the original research drug company Pfizer is expected to drop to 43.
71% in 2021
.
Another ED best-selling product, tadalafil tablets, is expected to decline slightly in physical pharmacies in Chinese cities in 2021, but sales remain above 700 million yuan, which is still difficult to directly compete with sildenafil citrate tablets.
, And Eli Lilly still occupies more than 80% of the market share, and it is difficult for domestic brands to make efforts
.
, And Eli Lilly still occupies more than 80% of the market share, and it is difficult for domestic brands to make efforts
.
Source: Company announcement, NMPA official website, Minet database
Note: Meinenet China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.
.
The above sales are calculated based on the average retail price of the product at the terminal
.
